Exploratory research on Anti-SARS-CoV-2 testing by the Blood Collection Device OneDraw

agao Miki0 个研究点目标入组 22 人开始时间: 2021年3月17日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 22

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

We measured COVID-19 anti-S antibodies in blood collected using a minimally invasive blood collection device and in serum collected by venous blood collection, and found that there was a correlation between the two samples.

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 20age old 至 ot applicable（—）
性别: All

入选标准

•COVID-19 patients confirmed by nucleic amplification testing
•Those who were vaccinated with COVID-19 vaccine at least 2 weeks ago

排除标准

未提供

研究者

发起方

agao Miki

相似试验

已完成

不适用

Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19Covid19

NCT04496141Hong Kong Sanatorium & Hospital70

已完成

不适用

Collection of Anti-SARS-CoV-2 Immune PlasmaCoronavirus Disease 2019 (COVID-19)

NCT04344977National Institute of Allergy and Infectious Diseases (NIAID)151

已完成

不适用

Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCRSARS-CoV InfectionPolymerase Chain ReactionLaboratory Testing

NCT04604145David Grant U.S. Air Force Medical Center60

尚未招募

不适用

T cell test for CoVID immunity

CTRI/2021/07/034670Yenepoya University

Unknown

不适用

Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF MethodSars-CoV2

NCT04429620Szeged University100